Wakely P E, Kornstein M J
Department of Pathology, Medical College of Virginia, Richmond 23298, USA.
Pediatr Pathol Lab Med. 1996 Mar-Apr;16(2):243-52.
Malignant lymphoma, lymphoblastic type (LL), and acute lymphoblastic leukemia (ALL) are two well-known pediatric malignancies whose diagnoses are typically established by surgical tissue biopsy and/or bone marrow examination. The status of fine-needle aspiration (FNA) biopsy in the diagnosis and management of these lymphoblastic malignancies is controversial. We present our experience from the past 7 years using FNA in children from 10 months to 15 years (mean age 10.5 years) of age with lymphoblastic cancers; in addition, two adult patients with ALL are included. Superficial FNA was performed in 16 cases (one patient had two aspirations 16 months apart). Eight patients were diagnosed with LL, six with ALL, and the one patient with two separate aspirates had lymphoblastic transformation of chronic myelogenous leukemia (CML). Five patients presented with the superior mediastinal syndrome. Sites of FNA included lymph node (nine cases), parotid gland (one), and soft tissues of the neck (four), buttock (one), and forehead (one). There were no complications from FNA. Except for one case (case 8), the patients with ALL and CML were previously diagnosed and treated for their disease, and FNA was performed primarily for the detection of disease recurrence. Conversely, in all eight children with LL, FNA was performed as the initial procedure to establish a primary diagnosis in previously well individuals. All eight LL patients responded-some dramatically-to chemotherapy. Two patients with LL and one with lymphoid blast crisis arising in CML had subsequent surgical biopsies that confirmed the FNA diagnosis. Immunophenotyping performed from 15 of 16 aspirates confirmed the T cell derivation of all cases of LL and 4 of 6 of ALL. Two of the ALL cases had a pre-B cell phenotype. Sufficient cells were obtained by FNA for flow cytometric DNA analysis in 9 of 16 cases. All cases but one were diploid, and 6 of 9 showed a high (> 6%) S phase. Our experience suggests that, when combined with immunologic phenotyping, definitive initial pathologic diagnosis of LL and recurrent ALL is possible and preferable using only aspiration cytopathology. It should be considered as part of the initial evaluation and management whenever a mass lesion appears in a child with a suspected lymphoblastic neoplasm. It can preclude the need for a surgically procured piece of tissue in those with a mediastinal mass and the superior mediastinal syndrome.
恶性淋巴瘤,淋巴细胞型(LL),和急性淋巴细胞白血病(ALL)是两种著名的儿科恶性肿瘤,其诊断通常通过手术组织活检和/或骨髓检查来确立。细针穿刺抽吸(FNA)活检在这些淋巴细胞性恶性肿瘤的诊断和治疗中的地位存在争议。我们介绍了过去7年中对年龄在10个月至15岁(平均年龄10.5岁)的患有淋巴细胞性癌症儿童使用FNA的经验;此外,还纳入了两名成年ALL患者。16例进行了浅表FNA(1例患者在相隔16个月的时间里进行了两次抽吸)。8例患者被诊断为LL,6例为ALL,而进行了两次单独抽吸的那例患者患有慢性粒细胞白血病(CML)的淋巴细胞转化。5例患者出现上腔静脉综合征。FNA的部位包括淋巴结(9例)、腮腺(1例)以及颈部软组织(4例)、臀部(1例)和前额(1例)。FNA未出现并发症。除1例(病例8)外,ALL和CML患者之前已被诊断并接受过疾病治疗,FNA主要用于检测疾病复发。相反,在所有8例LL患儿中,FNA作为初步检查用于在之前健康的个体中确立初步诊断。所有8例LL患者对化疗均有反应——有些反应显著。2例LL患者和1例CML发生淋巴母细胞危象的患者随后接受了手术活检,证实了FNA诊断。16例抽吸样本中的15例进行的免疫表型分析证实所有LL病例以及6例ALL中的4例为T细胞来源。2例ALL病例具有前B细胞表型。16例中有9例通过FNA获得了足够的细胞用于流式细胞术DNA分析。除1例病例外,所有病例均为二倍体,9例中有6例显示S期比例高(>6%)。我们的经验表明,当与免疫表型分析相结合时,仅使用针吸细胞病理学就有可能且更可取地对LL和复发性ALL进行明确的初始病理诊断。每当疑似淋巴细胞性肿瘤的儿童出现肿块病变时,应将其视为初始评估和治疗的一部分。对于患有纵隔肿块和上腔静脉综合征的患者,它可以避免获取手术组织样本的必要性。